Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 414301 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 445901 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 489449 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 496262 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 498481 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 507903 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 508488 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 510134 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 511685 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 524727 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 539032 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 542977 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 561462 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M+CL)- | 578330 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M-H)- | 154352 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M-H)- | 154376 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M-H)- | 167204 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M-H)- | 170644 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M-H)- | 177578 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M-H)- | 178567 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M-H)- | 180137 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M-H)- | 180255 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M-H)- | 184460 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M-H)- | 185701 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M-H)- | 192657 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M-H)- | 193986 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M-H)- | 203536 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | ZEATIN [ISTD] (M-H)- | 211061 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (M+H)+ | 1938437 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (M+H)+ | 1959655 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (M+H)+ | 1967072 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (M+H)+ | 1988262 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (M+H)+ | 1998307 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (M+H)+ | 2002556 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (M+H)+ | 2011879 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (M+H)+ | 2012530 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (M+H)+ | 2014024 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (M+H)+ | 2021465 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (M+H)+ | 2024307 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (M+H)+ | 2036142 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (M+H)+ | 2037226 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | ZEATIN [ISTD] (M+H)+ | 2041717 | Peak area normalized | male | diabetic | Neuropathy |